Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Systematic Review Article

Predictive Role of BNP/NT-proBNP in Non-Heart Failure Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Systematic Review

Author(s): Nikolaos Papageorgiou *, Rui Providência, Debbie Falconer, Tanakal Wongwarawipat, Dimitris Tousoulis, Wei Yao Lim , Anthony W. Chow, Richard J. Schilling and Pier D. Lambiase

Volume 27, Issue 27, 2020

Page: [4469 - 4478] Pages: 10

DOI: 10.2174/0929867326666191213095554

Price: $65

Open Access Journals Promotions 2
Abstract

Atrial Fibrillation (AF) is a growing public health issue, associated with significant morbidity and mortality. In addition to pharmacological therapy, catheter ablation is an effective strategy in restoring and maintaining sinus rhythm. However, ablation is not without risk, and AF recurs in a significant proportion of patients. Non-invasive, easily accessible markers or indices that could stratify patients depending on the likelihood of a successful outcome following ablation would allow us to select the most appropriate patients for the procedure, reducing the AF recurrence rate and exposure to potentially life-threatening risks.

There has been much attention paid to Brain Natriuretic Peptide (BNP) and N-Terminal prohormone of Brain Natriuretic Peptide (NT-proBNP) as possible predictive markers of successful ablation. Several studies have demonstrated an association between higher pre-ablation levels of these peptides, and a greater likelihood of AF recurrence. Therefore, there may be a role for measuring brain natriuretic peptides levels when selecting patients for catheter ablation.

Keywords: Atrial Fibrillation (AF), ablation, Brain Natriuretic Peptide (BNP), N-terminal BNP, catheter ablation, recurrence.

« Previous Next »
[1]
Nattel, S. New ideas about atrial fibrillation 50 years on. Nature, 2002, 415(6868), 219-226.
[http://dx.doi.org/10.1038/415219a] [PMID: 11805846]
[2]
Zoni-Berisso, M.; Lercari, F.; Carazza, T.; Domenicucci, S. Epidemiology of atrial fibrillation: European perspective. Clin. Epidemiol., 2014, 6, 213-220.
[http://dx.doi.org/10.2147/CLEP.S47385] [PMID: 24966695]
[3]
Jaïs, P.; Haïssaguerre, M.; Shah, D.C.; Chouairi, S.; Gencel, L.; Hocini, M.; Clémenty, J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation, 1997, 95(3), 572-576.
[http://dx.doi.org/10.1161/01.CIR.95.3.572] [PMID: 9024141]
[4]
Haïssaguerre, M.; Jaïs, P.; Shah, D.C.; Takahashi, A.; Hocini, M.; Quiniou, G.; Garrigue, S.; Le Mouroux, A.; Le Métayer, P.; Clémenty, J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med., 1998, 339(10), 659-666.
[http://dx.doi.org/10.1056/NEJM199809033391003] [PMID: 9725923]
[5]
Verma, A.; Jiang, C.Y.; Betts, T.R.; Chen, J.; Deisenhofer, I.; Mantovan, R.; Macle, L.; Morillo, C.A.; Haverkamp, W.; Weerasooriya, R.; Albenque, J.P.; Nardi, S.; Menardi, E.; Novak, P.; Sanders, P.; Investigators, S.A.I. STAR AF II Investigators. Approaches to catheter ablation for persistent atrial fibrillation. N. Engl. J. Med., 2015, 372(19), 1812-1822.
[http://dx.doi.org/10.1056/NEJMoa1408288] [PMID: 25946280]
[6]
Degener, S.; Pattberg, S.V.; Feuersenger, H.; Bansmann, P.M.; Shin, D.I.; Krummenauer, F.; Horlitz, M. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation. J. Interv. Card. Electrophysiol., 2011, 30(3), 217-225.
[http://dx.doi.org/10.1007/s10840-010-9540-2] [PMID: 21249437]
[7]
Cheema, A.; Vasamreddy, C.R.; Dalal, D.; Marine, J.E.; Dong, J.; Henrikson, C.A.; Spragg, D.; Cheng, A.; Nazarian, S.; Sinha, S.; Halperin, H.; Berger, R.; Calkins, H. Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J. Interv. Card. Electrophysiol., 2006, 15(3), 145-155.
[http://dx.doi.org/10.1007/s10840-006-9005-9] [PMID: 17019636]
[8]
Weber, M.; Hamm, C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart, 2006, 92(6), 843-849.
[http://dx.doi.org/10.1136/hrt.2005.071233] [PMID: 16698841]
[9]
Ellinor, P.T.; Low, A.F.; Patton, K.K.; Shea, M.A.; Macrae, C.A. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J. Am. Coll. Cardiol., 2005, 45(1), 82-86.
[http://dx.doi.org/10.1016/j.jacc.2004.09.045] [PMID: 15629379]
[10]
Rossi, A.; Enriquez-Sarano, M.; Burnett, J.C., Jr; Lerman, A.; Abel, M.D.; Seward, J.B. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and doppler-echocardiographic study. J. Am. Coll. Cardiol., 2000, 35(5), 1256-1262.
[http://dx.doi.org/10.1016/S0735-1097(00)00515-5] [PMID: 10758968]
[11]
Darkner, S.; Goetze, J.P.; Chen, X.; Henningsen, K.; Pehrson, S.; Svendsen, J.H. Natriuretic propeptides as markers of atrial fibrillation burden and recurrence (from the AMIO-CAT Trial). Am. J. Cardiol., 2017, 120(8), 1309-1315.
[http://dx.doi.org/10.1016/j.amjcard.2017.07.018] [PMID: 28865890]
[12]
Silvet, H.; Young-Xu, Y.; Walleigh, D.; Ravid, S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am. J. Cardiol., 2003, 92(9), 1124-1127.
[http://dx.doi.org/10.1016/j.amjcard.2003.07.010] [PMID: 14583372]
[13]
Bai, M.; Yang, J.; Li, Y. Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation. Clin. Cardiol., 2009, 32(12), E1-E5.
[http://dx.doi.org/10.1002/clc.20478] [PMID: 20014208]
[14]
Knudsen, C.W.; Omland, T.; Clopton, P.; Westheim, A.; Wu, A.H.; Duc, P.; McCord, J.; Nowak, R.M.; Hollander, J.E.; Storrow, A.B.; Abraham, W.T.; McCullough, P.A.; Maisel, A. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J. Am. Coll. Cardiol., 2005, 46(5), 838-844.
[http://dx.doi.org/10.1016/j.jacc.2005.05.057] [PMID: 16139134]
[15]
Inoue, S.; Murakami, Y.; Sano, K.; Katoh, H.; Shimada, T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J. Card. Fail., 2000, 6(2), 92-96.
[http://dx.doi.org/10.1016/S1071-9164(00)90010-1] [PMID: 10908082]
[16]
Ma, X.X.; Zhang, Y.L.; Hu, B.; Jiang, W.J.; Wang, M.; Zheng, D.Y.; Zhu, M.R.; Xue, X.P. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation. J. Interv. Card. Electrophysiol., 2017, 48(3), 343-350.
[http://dx.doi.org/10.1007/s10840-016-0216-4] [PMID: 27943042]
[17]
Jourdain, P.; Bellorini, M.; Funck, F.; Fulla, Y.; Guillard, N.; Loiret, J.; Thebault, B.; Sadeg, N.; Desnos, M. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur. J. Heart Fail., 2002, 4(3), 263-267.
[http://dx.doi.org/10.1016/S1388-9842(02)00004-1] [PMID: 12034150]
[18]
Wozakowska-Kapłon, B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am. J. Cardiol., 2004, 93(12), 1555-1558.
[http://dx.doi.org/10.1016/j.amjcard.2004.03.013] [PMID: 15194036]
[19]
Svennberg, E.; Henriksson, P.; Engdahl, J.; Hijazi, Z.; Al-Khalili, F.; Friberg, L.; Frykman, V. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation. Heart, 2017, 103(16), 1271-1277.
[http://dx.doi.org/10.1136/heartjnl-2016-310236] [PMID: 28255099]
[20]
Yamada, T.; Murakami, Y.; Okada, T.; Yoshida, N.; Toyama, J.; Yoshida, Y.; Tsuboi, N.; Inden, Y.; Hirai, M.; Murohara, T. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace, 2007, 9(9), 770-774.
[http://dx.doi.org/10.1093/europace/eum157] [PMID: 17670784]
[21]
Xing, S.Y.; Wang, H.L.; Dong, P.S.; Lai, L.H.; Zhu, J.H.; Zhao, J.F.; Shang, X.Y. Clinical significance and levels of blood brain natriuretic peptides in patients with persistent atrial fibrillation before and after catheter ablation. Genet. Mol. Res., 2015, 14(2), 6953-6959.
[http://dx.doi.org/10.4238/2015.June.26.3] [PMID: 26125903]
[22]
Date, T.; Yamane, T.; Inada, K.; Matsuo, S.; Miyanaga, S.; Sugimoto, K.; Shibayama, K.; Taniguchi, I.; Mochizuki, S. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. Heart, 2006, 92(11), 1623-1627.
[http://dx.doi.org/10.1136/hrt.2005.083022] [PMID: 16740921]
[23]
Ata, Y.; Turk, T.; Ay, D.; Eris, C.; Demir, M.; Ari, H.; Ata, F.; Yavuz, S.; Ozyazicioglu, A. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Heart Surg. Forum, 2009, 12(4), E211-E216.
[http://dx.doi.org/10.1532/HSF98.20091014] [PMID: 19683991]
[24]
Iskesen, I.; Eserdag, M.; Kurdal, A.T.; Cerrahoglu, M.; Sirin, B.H. Preoperative NT-proBNP levels: a reliable parameter to estimate postoperative atrial fibrillation in coronary artery bypass patients. Thorac. Cardiovasc. Surg., 2011, 59(4), 213-216.
[http://dx.doi.org/10.1055/s-0030-1250356] [PMID: 21394710]
[25]
Wazni, O.M.; Martin, D.O.; Marrouche, N.F.; Latif, A.A.; Ziada, K.; Shaaraoui, M.; Almahameed, S.; Schweikert, R.A.; Saliba, W.I.; Gillinov, A.M.; Tang, W.H.; Mills, R.M.; Francis, G.S.; Young, J.B.; Natale, A. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation, 2004, 110(2), 124-127.
[http://dx.doi.org/10.1161/01.CIR.0000134481.24511.BC] [PMID: 15210589]
[26]
Amar, D.; Zhang, H.; Shi, W.; Downey, R.J.; Bains, M.S.; Park, B.J.; Flores, R.; Rizk, N.; Thaler, H.T.; Rusch, V.W. Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. J. Thorac. Cardiovasc. Surg., 2012, 144(5), 1249-1253.
[http://dx.doi.org/10.1016/j.jtcvs.2012.06.051] [PMID: 22841166]
[27]
Horie, H.; Tsutamoto, T.; Minai, K.; Hayashi, M.; Kito, O.; Kinoshita, M. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn. Circ. J., 2000, 64(12), 965-970.
[http://dx.doi.org/10.1253/jcj.64.965] [PMID: 11194292]
[28]
Marsiliani, D.; Buccelletti, F.; Carroccia, A.; Gilardi, E.; Silveri, N.G.; Franceschi, F. Natriuretic peptides and atrial fibrillation. Eur. Rev. Med. Pharmacol. Sci., 2010, 14(10), 855-860.
[PMID: 21222371]
[29]
Ruggiero, F.; Santini, L.; Gallagher, M.M.; Papavasileiou, L.P.; Romano, V.; Canziani, F.; D’annibale, S.; Romeo, F. Changes in brain natriuretic peptide level as a predictor of AF recurrence after electrical cardioversion. Minerva Cardioangiol., 2011, 59(2), 135-138.
[PMID: 21368733]
[30]
Ari, H.; Binici, S.; Ari, S.; Akkaya, M.; Koca, V.; Bozat, T.; Gürdoğan, M. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Turk Kardiyol. Dern. Ars., 2008, 36(7), 456-460.
[PMID: 19155659]
[31]
Lellouche, N.; Berthier, R.; Mekontso-Dessap, A.; Braconnier, F.; Monin, J.L.; Duval, A.M.; Dubois-Randé, J.L.; Guéret, P.; Garot, J. Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. Am. J. Cardiol., 2005, 95(11), 1380-1382.
[http://dx.doi.org/10.1016/j.amjcard.2005.01.090] [PMID: 15904651]
[32]
Beck-da-Silva, L.; de Bold, A.; Fraser, M.; Williams, K.; Haddad, H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can. J. Cardiol., 2004, 20(12), 1245-1248.
[PMID: 15494777]
[33]
Freynhofer, M.K.; Jarai, R.; Höchtl, T.; Bruno, V.; Vogel, B.; Aydinkoc, K.; Nürnberg, M.; Wojta, J.; Huber, K. Predictive value of plasma Nt-proBNP and body mass index for recurrence of atrial fibrillation after cardioversion. Int. J. Cardiol., 2011, 149(2), 257-259.
[http://dx.doi.org/10.1016/j.ijcard.2011.02.043] [PMID: 21377224]
[34]
Tveit, A.; Seljeflot, I.; Grundvold, I.; Abdelnoor, M.; Arnesen, H.; Smith, P. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion. Int. J. Cardiol., 2009, 131(2), 234-239.
[http://dx.doi.org/10.1016/j.ijcard.2007.10.028] [PMID: 18201783]
[35]
Xu, X.; Tang, Y. Relationship between brain natriuretic peptide and recurrence of atrial fibrillation after successful electrical cardioversion: an updated meta-analysis. Rev. Bras. Cir. Cardiovasc., 2017, 32(6), 530-535.
[http://dx.doi.org/10.21470/1678-9741-2017-0008] [PMID: 29267617]
[36]
Ioannou, A.; Papageorgiou, N.; Falconer, D.; Rehal, O.; Sewart, E.; Zacharia, E.; Toutouzas, K.; Vlachopoulos, C.; Siasos, G.; Tsioufis, C.; Tousoulis, D. Biomarkers associated with stroke risk in atrial fibrillation. Curr. Med. Chem., 2019, 26(5), 803-823.
[http://dx.doi.org/10.2174/0929867324666170718120651] [PMID: 28721825]
[37]
Hijazi, Z.; Oldgren, J.; Andersson, U.; Connolly, S.J.; Ezekowitz, M.D.; Hohnloser, S.H.; Reilly, P.A.; Vinereanu, D.; Siegbahn, A.; Yusuf, S.; Wallentin, L. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation, 2012, 125(13), 1605-1616.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.038729] [PMID: 22374183]
[38]
Hijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Christersson, C.; Ezekowitz, J.; Gersh, B.J.; Hanna, M.; Hohnloser, S.; Horowitz, J.; Huber, K.; Hylek, E.M.; Lopes, R.D.; McMurray, J.J.; Granger, C.B. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE trial (apixaban for the prevention of stroke in subjects with atrial fibrillation). J. Am. Coll. Cardiol., 2013, 61(22), 2274-2284.
[http://dx.doi.org/10.1016/j.jacc.2012.11.082] [PMID: 23563134]
[39]
Shin, D.I.; Deneke, T.; Gorr, E.; Anders, H.; Buenz, K.; Paesler, M.; Horlitz, M. Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic peptide plasma levels. Indian Pacing Electrophysiol. J., 2009, 9(5), 241-246.
[PMID: 19763191]
[40]
Mohanty, S.; Mohanty, P.; Di Biase, L.; Rong, B.; Burkhardt, D.; Gallinghouse, J.G.; Horton, R.; Sanchez, J.E.; Bailey, S.; Zagrodzky, J.; Natale, A. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure outcome in atrial fibrillation patients undergoing catheter ablation. J. Cardiovasc. Electrophysiol., 2011, 22(8), 858-865.
[http://dx.doi.org/10.1111/j.1540-8167.2011.02036.x] [PMID: 21371160]
[41]
Patel, D.; Mohanty, P.; Di Biase, L.; Sanchez, J.E.; Shaheen, M.H.; Burkhardt, J.D.; Bassouni, M.; Cummings, J.; Wang, Y.; Lewis, W.R.; Diaz, A.; Horton, R.P.; Beheiry, S.; Hongo, R.; Gallinghouse, G.J.; Zagrodzky, J.D.; Bailey, S.M.; Al-Ahmad, A.; Wang, P.; Schweikert, R.A.; Natale, A. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm, 2010, 7(2), 167-172.
[http://dx.doi.org/10.1016/j.hrthm.2009.10.025] [PMID: 20022814]
[42]
Pillarisetti, J.; Reddy, N.; Biria, M.; Ryschon, K.; Nagarajan, D.; Murray, C.; Atkins, D.; Bommana, S.; Reddy, M.Y.; DiBiase, L.; Pimentel, R.; Berenbom, L.; Dawn, B.; Natale, A.; Lakkireddy, D. Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time? J. Interv. Card. Electrophysiol., 2014, 40(2), 161-168.
[http://dx.doi.org/10.1007/s10840-014-9898-7] [PMID: 24800931]
[43]
Machino-Ohtsuka, T.; Seo, Y.; Tada, H.; Ishizu, T.; Machino, T.; Yamasaki, H.; Igarashi, M.; Xu, D.; Sekiguchi, Y.; Aonuma, K. Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. J. Cardiovasc. Electrophysiol., 2011, 22(9), 999-1006.
[http://dx.doi.org/10.1111/j.1540-8167.2011.02049.x] [PMID: 21457382]
[44]
Yamada, T.; Murakami, Y.; Okada, T.; Yoshida, N.; Toyama, J.; Yoshida, Y.; Tsuboi, N.; Inden, Y.; Hirai, M.; Murohara, T. Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation. Int. Heart J., 2008, 49(2), 143-151.
[http://dx.doi.org/10.1536/ihj.49.143] [PMID: 18475014]
[45]
Yamada, T.; Murakami, Y.; Okada, T.; Okamoto, M.; Shimizu, T.; Toyama, J.; Yoshida, Y.; Tsuboi, N.; Ito, T.; Muto, M.; Kondo, T.; Inden, Y.; Hirai, M.; Murohara, T. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation. Am. J. Cardiol., 2006, 97(12), 1741-1744.
[http://dx.doi.org/10.1016/j.amjcard.2005.12.071] [PMID: 16765125]
[46]
Kurosaki, K.; Tada, H.; Hashimoto, T.; Ito, S.; Miyaji, K.; Naito, S.; Oshima, S.; Taniguchi, K. Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circ. J., 2007, 71(3), 313-320.
[http://dx.doi.org/10.1253/circj.71.313] [PMID: 17322627]
[47]
Fan, J.; Cao, H.; Su, L.; Ling, Z.; Liu, Z.; Lan, X.; Xu, Y.; Chen, W.; Yin, Y. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation. J. Interv. Card. Electrophysiol., 2012, 33(1), 93-100.
[http://dx.doi.org/10.1007/s10840-011-9606-9] [PMID: 21938519]
[48]
Hwang, H.J.; Son, J.W.; Nam, B.H.; Joung, B.; Lee, B.; Kim, J.B.; Lee, M.H.; Jang, Y.; Chung, N.; Shim, W.H.; Cho, S.Y.; Kim, S.S. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation. Clin. Res. Cardiol., 2009, 98(4), 213-218.
[http://dx.doi.org/10.1007/s00392-009-0744-3] [PMID: 19229464]
[49]
den Uijl, D.W.; Delgado, V.; Tops, L.F.; Ng, A.C.; Boersma, E.; Trines, S.A.; Zeppenfeld, K.; Schalij, M.J.; van der Laarse, A.; Bax, J.J. Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation. Am. Heart J., 2011, 161(1), 197-203.
[http://dx.doi.org/10.1016/j.ahj.2010.09.031] [PMID: 21167354]
[50]
Giannopoulos, G.; Kossyvakis, C.; Angelidis, C.; Efremidis, M.; Panagopoulou, V.; Letsas, K.; Bouras, G.; Vassilikos, V.P.; Goudevenos, J.; Tousoulis, D.; Lekakis, J.; Deftereos, S. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation. Heart Rhythm, 2015, 12(7), 1470-1475.
[http://dx.doi.org/10.1016/j.hrthm.2015.04.002] [PMID: 25847478]
[51]
Arana-Rueda, E.; Pedrote, A.; García-Riesco, L.; Arce-León, Á.; Guerrero-Márquez, F.; Rodríguez-Rodríguez, J. [Clinical value of N-terminal pro-B-type natriuretic peptide measurement in the follow up of pulmonary vein ablation]. Med. Clin. (Barc.), 2015, 145(6), 248-250.
[http://dx.doi.org/10.1016/j.medcli.2014.10.018] [PMID: 25561181]
[52]
Jiang, H.; Wang, W.; Wang, C.; Xie, X.; Hou, Y. Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis. Europace, 2017, 19(3), 392-400.
[http://dx.doi.org/10.1093/europace/euw088s] [PMID: 27386883]
[53]
Thamilarasan, M.; Klein, A.L. Factors relating to left atrial enlargement in atrial fibrillation: “chicken or the egg” hypothesis. Am. Heart J., 1999, 137(3), 381-383.
[http://dx.doi.org/10.1016/S0002-8703(99)70481-3] [PMID: 10047615]
[54]
Plitt, D.C.; Chung, E.H.; Mounsey, J.P.; Schwartz, J.D.; Pursell, I.W.; Gehi, A.K. Relation of atrial fibrillation burden and N-terminal pro-brain natriuretic peptide. Am. J. Cardiol., 2013, 111(9), 1315-1318.
[http://dx.doi.org/10.1016/j.amjcard.2013.01.273] [PMID: 23415637]
[55]
Anter, E.; Jessup, M.; Callans, D.J. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation, 2009, 119(18), 2516-2525.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.108.821306] [PMID: 19433768]
[56]
Li, D.; Fareh, S.; Leung, T.K.; Nattel, S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation, 1999, 100(1), 87-95.
[http://dx.doi.org/10.1161/01.CIR.100.1.87] [PMID: 10393686]
[57]
Beuckelmann, D.J.; Näbauer, M.; Erdmann, E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation, 1992, 85(3), 1046-1055.
[http://dx.doi.org/10.1161/01.CIR.85.3.1046] [PMID: 1311223]
[58]
Carballo, D.; Noble, S.; Carballo, S.; Stirnemann, J.; Muller, H.; Burri, H.; Vuilleumier, N.; Talajic, M.; Tardif, J.C.; Keller, P.F.; Mach, F.; Shah, D. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation. J. Int. Med. Res., 2018, 46(12), 5183-5194.
[http://dx.doi.org/10.1177/0300060518793807] [PMID: 30178684]
[59]
Henningsen, K.M.A.; Nilsson, B.; Bruunsgaard, H.; Chen, X.; Pedersen, B.K.; Svendsen, J.H. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Scand. Cardiovasc. J., 2009, 43(5), 285-291.
[http://dx.doi.org/10.1080/14017430802653676] [PMID: 19117239]
[60]
Wu, N.; Xu, B.; Xiang, Y.; Wu, L.; Zhang, Y.; Ma, X.; Tong, S.; Shu, M.; Song, Z.; Li, Y.; Zhong, L. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int. J. Cardiol., 2013, 169(1), 62-72.
[http://dx.doi.org/10.1016/j.ijcard.2013.08.078] [PMID: 24095158]
[61]
Nakanishi, K.; Fukuda, S.; Yamashita, H.; Hasegawa, T.; Kosaka, M.; Shirai, N.; Shimada, K.; Yoshikawa, J.; Tanaka, A. High-sensitive cardiac troponin T as a novel predictor for recurrence of atrial fibrillation after radiofrequency catheter ablation. Europace, 2017, 19(12), 1951-1957.
[http://dx.doi.org/10.1093/europace/euw314] [PMID: 28069837]
[62]
Wu, X.Y.; Li, S.N.; Wen, S.N.; Nie, J.G.; Deng, W.N.; Bai, R.; Liu, N.; Tang, R.B.; Zhang, T.; Du, X.; Dong, J.Z.; Ma, C.S. Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease. Europace, 2015, 17(10), 1541-1547.
[http://dx.doi.org/10.1093/europace/euv045] [PMID: 25921557]
[63]
Zhou, Q.; Maleck, C.; von Ungern-Sternberg, S.N.I.; Neupane, B.; Heinzmann, D.; Marquardt, J.; Duckheim, M.; Scheckenbach, C.; Stimpfle, F.; Gawaz, M.; Schreieck, J.; Seizer, P.; Gramlich, M. Circulating microRNA-21 correlates with left atrial low-voltage areas and is associated with procedure outcome in patients undergoing atrial fibrillation ablation. Circ. Arrhythm. Electrophysiol., 2018, 11(6), e006242.
[http://dx.doi.org/10.1161/CIRCEP.118.006242] [PMID: 29848477]
[64]
Mohanty, S.; Hall, A.W.; Mohanty, P.; Prakash, S.; Trivedi, C.; Di Biase, L.; Santangeli, P.; Bai, R.; Burkhardt, J.D.; Gallinghouse, G.J.; Horton, R.; Sanchez, J.E.; Hranitzky, P.M.; Al-Ahmad, A.; Iyer, V.R.; Natale, A. Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF). J. Interv. Card. Electrophysiol., 2016, 45(1), 7-17.
[http://dx.doi.org/10.1007/s10840-015-0069-2] [PMID: 26497660]
[65]
Deftereos, S.; Giannopoulos, G.; Kossyvakis, C.; Efremidis, M.; Panagopoulou, V.; Kaoukis, A.; Raisakis, K.; Bouras, G.; Angelidis, C.; Theodorakis, A.; Driva, M.; Doudoumis, K.; Pyrgakis, V.; Stefanadis, C. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J. Am. Coll. Cardiol., 2012, 60(18), 1790-1796.
[http://dx.doi.org/10.1016/j.jacc.2012.07.031] [PMID: 23040570]

Rights & Permissions Print Cite
Article Metrics
35
1
Wayfinder Image
Open Access Journals Promotions
World Antimicrobial Awareness Week
© 2024 Bentham Science Publishers | Privacy Policy